Product Information
ESTARYLLA 0.25-0.035 MG TABLET is a generic product labeled by Xiromed LLC, priced at $0.1148 per EA under NDC 70700011985. Its NADAC has been published 425 times since Aug 15, 2018.
FDA first approved this application on Jan 30, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700011985
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA090794FDA Approved
1/30/2013
TE Code
AB
On Market Since
1/1/2018
Price Statistics
The NADAC for ESTARYLLA 0.25-0.035 MG TABLET has been published 425 times since Aug 15, 2018, and over the history we have for it it has declined 55.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1148 per EA |
|---|---|
| All-time high | $0.2653 (Nov 14, 2018) |
| All-time low | $0.1011 (Nov 20, 2024) |
| 52-week high | $0.1275 |
| 52-week low | $0.1148 |
| Median price | $0.1507 |
| Average price | $0.1745 |
| Largest weekly change | -21.9% (Nov 20, 2024) |
| Weeks tracked | 425 |
| Tracking since | Aug 15, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norgestimate and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESTARYLLA 0.25-0.035 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESTARYLLA 0.25-0.035 MG TABLET, manufactured by Xiromed LLC, is $0.1148 per EA (NDC 70700011985), effective Sep 30, 2026.
How has the price of ESTARYLLA 0.25-0.035 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESTARYLLA 0.25-0.035 MG TABLET has declined 55.8%. It has been tracked across 425 weekly CMS publications since Aug 15, 2018.
What are the highest and lowest recorded NADAC prices for ESTARYLLA 0.25-0.035 MG TABLET?
Since Aug 15, 2018, the NADAC for ESTARYLLA 0.25-0.035 MG TABLET has ranged from a low of $0.1011 (Nov 20, 2024) to a high of $0.2653 (Nov 14, 2018), with a median of $0.1507 per EA.
Are there cheaper alternatives to ESTARYLLA 0.25-0.035 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ESTARYLLA 0.25-0.035 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ESTARYLLA 0.25-0.035 MG TABLET?
ESTARYLLA 0.25-0.035 MG TABLET (NDC 70700011985) is labeled by Xiromed LLC, and CMS classifies it as a generic product.